Alnylam Pharmaceuticals
ALNY
#586
Rank
NZ$58.24 B
Marketcap
$451.60
Share price
-1.45%
Change (1 day)
62.02%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company